Two sessions webinar - Totally Implanted Ports: Enhance your practice with the CAVA comparative analysis and expert insights

Time zones: 

- London: 4 p.m. 

- Berlin: 5 p.m.

- New-York: 11 a.m.

- Dubai: 8 p.m.

- New Delhi: 9:30 p.m

• Webinar One: Central venous access devices for the delivery of systemic anticancer therapy (CAVA): randomized control trial

During this first webinar, Professor Jon Moss will provide a detailed overview of the Cancer and Venous Access (CAVA) study that he led.

- CAVA Trial Overview:

The Cancer and Venous Access (CAVA) trial is a significant clinical study that investigated the optimal use of long-term vascular access devices in cancer patients who require chemotherapy. The primary objective of the trial was to evaluate the efficacy and safety of different vascular access options, such as totally implanted ports, peripherally inserted catheters and tunnelled cuffed catheters, in terms of patient outcomes, complication rates, and quality of life. Given that many treatments often require repeated intravenous infusions and blood sampling, the choice of vascular access can critically influence the patient's treatment experience and overall health trajectory.

In the 2nd half of the webinar, Dr Robert Heggie will discuss and summarise the cost analysis of the CAVA trial.

- Cost Analysis Focus:

In addition to clinical outcomes, the CAVA trial includes a comprehensive cost analysis that explores the financial implications of using various long-term vascular access devices. will present a health economic evaluation of the comparison of Port, PICC and Hickman devices, based on the results of the CAVA clinical trial. The presentation will summarise the cost analysis of the CAVA trial included within the Lancet publication, the limitations of this analysis, and how this was addressed with a more comprehensive cost-consequence analysis of a wide range of clinical and economic outcomes published in the Value and Health Journal. 

- Why attend this session:

Attending our session on the CAVA trial and its cost analysis will equip healthcare professionals, researchers, and stakeholders with vital information on the latest evidence-based practices regarding vascular access. You will gain insights into optimal device selection, management protocols, and cost-effective strategies that can enhance care delivery and improve patient outcomes. Furthermore, the discussions will highlight innovative solutions and potential future directions in vascular access technologies. This is an excellent opportunity for networking and collaboration among healthcare professionals committed to advancing patient care. Your participation will contribute to shaping the future of vascular access in healthcare.

- Chair: 

The chair of this webinar is Dr Knut Taxbro.

Knut is a consultant anaesthetist/intensivist and an adjunct senior lecturer at Linköping University. He is the clinical lead for the Acute Care and Trauma unit in Jönköping and a HEMS physician in Gothenburg, Sweden. In 2019, he published his doctoral thesis on vascular access in cancer, which included the first large randomized trial comparing PICCs with ports in cancer patients, published in the British Journal of Anaesthesia. He is currently involved in other RCTs in the vascular access field. He was a panellist at the MAGIC-oncology consensus group meeting in Colorado in October 2024.

• Webinar Two: Implantable port service development: insights from interventional radiologists and nurses

The insertion of totally implanted venous access devices (ports) are delivered in the radiology departments in many hospitals. In this session, Dr Ram Kasthuri will present his experiences of working using a model which is currently delivered by the interventional radiologists. Within his unit however, a hybrid model is being planned. This plan is with active involvement of the hospital management. They already have a funded model which can site and maintain up to 250 ports per year and involves free access to advice for the end users with any queries and direct patient assessment abilities should this be required. The aims of this presentation will be to provide:
 
1.    A brief description of port insertion and removal techniques. 
2.    A summary of common challenges in the management of the devices. 
3.    If required, discuss the role of the radiologist in a hybrid model. 

- Nurse led port service:

In addition to radiologist led port insertion services, nurse led port services are being more popular in many countries. In the 2nd part of this webinar, Aldwin Del Mundo will discuss the development of his PICC port service at St Georges Hospital in England. This presentation will include the following:
1.    Why the service was developed  
3.    Why they changed from PICC to PICC-Port
4.    Data will be presented
5.    The change process will be presented  
6.    Hints and tips of business case production will be offered.

- Why attend this session: 

This webinar will provide a comprehensive overview of these two approaches to port insertion services, facilitating informed decision-making for healthcare professionals and administrators involved in patient care.